Patents Examined by My-Chau Tran
-
Patent number: 6867010Abstract: A method for in vitro selection, from a library of catalyst molecules, of a catalyst molecule of interest having a relatively more efficient specific catalytic activity of interest, as compared to the rest of the catalyst molecules within said library, and wherein said in vitro selection method is characterized by that it allows multiple catalytic activity turn-overs (i.e. substrate to product catalytic activity turn-overs), by the catalyst molecule of interest, before it is finally collected. The method is based on using one or more reagent(s) which are capable of converting a product generated by a catalyst molecule of interest back into the substrate for said catalyst of interest.Type: GrantFiled: September 7, 1999Date of Patent: March 15, 2005Inventors: Henrik Pedersen, Swen Hölder, Jorgen Kjems, Mette Katrine Lund
-
Patent number: 6852289Abstract: Methods and apparatus for qualitatively or quantitatively determining one or more analytes in matrices such as foods, biological fluids, etc. An embodiment for determination of a single analyte comprises a sample receiving vessel, a first membrane and a reagent-containing well. The prepared sample passes through the first membrane whereby extraneous matter is removed, and a filtrate enters the reagent-containing well to provide a filtrate-reagent admixture from which the analyte may be determined. An embodiment for determination for multiple analytes includes one or more additional membranes in series with the first membrane, each such additional membrane being operative to capture one or more analytes. Each of the additional analytes may then be eluted from the membrane upon which it has been captured, into a separate reagent-containing well to provide eluant-reagent admixture from which each desired analyte may be determined. Formulations for preparation additives are also included.Type: GrantFiled: March 26, 2001Date of Patent: February 8, 2005Assignee: Saftest, Inc.Inventors: Virginia C. Gordon, Bennett W. Root, Jr., Barbara J. Peasley, John F. Elias, John T. Sorensen, Michael Mittelstein, Soheila Mirhashemi
-
Patent number: 6713298Abstract: A system for the rapid characterization of multi-analyte fluids, in one embodiment, includes a light source, a sensor array, and a detector. The sensor array is formed from a supporting member into which a plurality of cavities may be formed. A series of chemically sensitive particles are, in one embodiment positioned within the cavities. The particles may be configured to produce a signal when a receptor coupled to the particle interacts with the analyte. Using pattern recognition techniques, the analytes within a multi-analyte fluid may be characterized.Type: GrantFiled: January 31, 2001Date of Patent: March 30, 2004Assignee: Board of Regents, The University of Texas SystemInventors: John T. McDevitt, Eric V. Anslyn, Jason B. Shear, Dean P. Neikirk
-
Patent number: 6692699Abstract: A rubbed substrate structure for use in a liquid crystal assay device, includes: a biochemical blocking compound chemically immobilized on a surface of one side of a support forming a biochemical blocking layer; and a biomolecule recognition agent deposited on the side of the support containing the biochemical blocking layer. The biomolecule recognition agent includes a recognition site capable of selectively recognizing a target species to be detected by the liquid crystal assay device. Additionally, the surface of the side of the support containing the biochemical blocking layer is rubbed such that it possesses features that drive a uniform anchoring of liquid crystals when the liquid crystals contact the side of the support containing the biochemical blocking layer.Type: GrantFiled: February 15, 2001Date of Patent: February 17, 2004Assignee: Wisconsin Alumni Research FoundationInventors: Nicholas L. Abbott, Seung-Ryeol Kim
-
Patent number: 6673596Abstract: Disclosed are bioluminescent bioreporter integrated circuit devices that detect selected analytes in fluids when implanted in the body of an animal. The device comprises a bioreporter that has been genetically engineered to contain a nucleic acid segment that comprises a cis-activating response element that is responsive to the selected substance operably linked to a gene encoding a bioluminescent reporter polypeptide. In preferred embodiments, the target analyte is glucose, glucagons, or insulin. Exposure of the bioreporter to the target substance causes the response element to up-regulate the nucleic acid sequence encoding the reporter polypeptide to produce a luminescent response that is detected and quantitated. In illustrative embodiments, the bioreporter device is encapsulated on an integrated circuit that is capable of detecting the emitted light, processing the resultant signal, and then remotely reporting the results.Type: GrantFiled: December 2, 1999Date of Patent: January 6, 2004Assignees: UT-Battelle, LLC, University of Tennessee Research CorporationInventors: Gary S. Sayler, Michael L. Simpson, Bruce M. Applegate, Steven A. Ripp
-
Patent number: 6649403Abstract: A system for the rapid characterization of multi-analyte fluids, in one embodiment, includes a light source, a sensor array, and a detector. The sensor array is formed from a supporting member into which a plurality of cavities may be formed. A series of chemically sensitive particles are, in one embodiment positioned within the cavities. The particles may be configured to produce a signal when a receptor coupled to the particle interacts with the analyte. Using pattern recognition techniques, the analytes within a multi-analyte fluid may be characterized.Type: GrantFiled: January 31, 2001Date of Patent: November 18, 2003Assignee: Board of Regents, The University of Texas SystemsInventors: John T. McDevitt, Eric V. Anslyn, Jason B. Shear, Dean P. Neikirk
-
Patent number: 6376206Abstract: An immunoassay for the determination of myocardial necroses using antibodies to troponin T and a binding partner B for troponin T or for the an antibody, whereby either the antibody or the binding partner B is labelled with a determinable group. The immunological complex formed which contains the determinable group is isolated by separation of the phases and the determinable group is determined in one of the phases. Furthermore, monoclonal and polyclonal antibodies to troponin T are described with a cross-reactivity of less than 5% to skeletal muscle troponin T and less than 2% to troponin I and other myofibrillar proteins.Type: GrantFiled: June 7, 1995Date of Patent: April 23, 2002Assignee: Roche Diagnostics GmbHInventors: Hugo Katus, Anneliese Borgya, Klaus Hallermayer, Siegfried Looser